Browse
Submit Data
Databases
API
Help

Dataset Information

0 Views

0 Connections

0 Citations

0 Reanalyses

0 Downloads

Omics score: 0

MS-based Proteomics Analysis of Cerebrospinal Fluid from Niemann-Pick type C Disease Patients

ABSTRACT: MS-based proteomics dataset of CSF from NPC patients

INSTRUMENT(S): timsTOF Pro 2

ORGANISM(S): Homo Sapiens (ncbitaxon:9606)

SUBMITTER: Forbes D. Porter

PROVIDER: MSV000093519 | MassIVE | Tue Nov 28 08:13:00 GMT 2023

REPOSITORIES: MassIVE

ACCESS DATA

Json Xml

Dataset's files

Source:

			Action	DRS
		Other

Items per page:

1 - 1 of 1

Similar Datasets

A differential proteomics study of cerebrospinal fluid from individuals with Niemann-Pick disease, Type C1.

Project description: Not available

| S-EPMC10918788 | biostudies-literature

Human iNSC-derived brain organoid model of lysosomal storage disorder in Niemann-Pick disease type C

Project description:Recent studies on developing three-dimensional (3D) brain organoids from stem cells have allowed the generation of in vitro models of neural disease and have enabled the screening of drugs because these organoids mimic the complexity of neural tissue. Niemann-Pick disease, type C (NPC) is a neurodegenerative lysosomal storage disorder caused by mutations in the NPC1 protein. The pathological features underlying NPC are characterized by the abnormal accumulation of cholesterol in acidic compartments, including late endosomes and lysosomes. Due to the inaccessibility of brain tissues from human NPC patients, we developed NPC brain organoids with induced neural stem cells from NPC patient-derived fibroblasts. NPC organoids exhibit significantly reduced size and proliferative ability, which are accompanied by accumulation of cholesterol, impairment in neuronal differentiation and autophagic flux and dysfunction of lysosomes; therefore, NPC organoids can recapitulate the main phenotypes of NPC patients. Furthermore, these pathological phenotypes observed in NPC organoids were reversed by treatment with valproic acid, which is known to be an effective treatment for several neurodegenerative diseases. Our data present patient-specific phenotypes in 3D organoid-based models of NPC and highlight the application of this model to drug screening in vitro.

2020-12-21 | GSE157676 | GEO

Cerebrospinal Fluid Calbindin D Concentration as a Biomarker of Cerebellar Disease Progression in Niemann-Pick Type C1 Disease.

Project description: Not available

| S-EPMC4959104 | biostudies-literature

RNA-seq of Niemann-Pick Type C mouse microglia throughout disease course

Project description:Here we perform RNAsequencing on isolated microglia from wild-type and NP-C mice throughout disease course. We sequence microglia from WT and NPC mice at 1, 3, 6, and 9 weeks old. We also treat mice with the CSF1R inhibitor PLX5622 and sequence remaining microglia from treated and control mice.

2023-06-09 | GSE152158 | GEO

Elevated Cerebrospinal Fluid Total Tau in Niemann-Pick Disease Type C1: Correlation With Clinical Severity and Response to Therapeutic Interventions.

Project description: Not available

| S-EPMC11893204 | biostudies-literature

miRNA Expression from Cerebrospinal Fluid (CSF) from Prodromal Huntington Disease Patients

Project description:Analysis of microRNA (miRNA) expression in CSF from prodromal Huntington disease patients.

2020-05-10 | GSE150174 | GEO

Identification of cerebral spinal fluid protein biomarkers in Niemann-Pick disease, type C1.

Project description: Not available

| S-EPMC9887810 | biostudies-literature

lysosome proteomics in Niemann-Pick Type C disease model cells (CHOwt and NPC1-null cells)

Project description:Increasing evidence implicates lysosomal dysfunction in the pathogenesis of neurodegenerative diseases, including the rare inherited lysosomal storage disorders (LSDs) and the most common neurodegenerative diseases, such as Alzheimer’s and Parkinson’s disease (AD and PD). The goal of this work was to analyze whether there are changes in the lysosomal glycocalyx in a cellular model of a LSD Niemann-Pick type C disease (NPC). Using the ferrofluid nanoparticles we isolated lysosomal organelles from NPC1-null and CHOwt cells. Mass spectrometry identification of lysosomal proteins was performed in order to determine the enrichment efficiency for N-glycome profiling of the lysosomal glycocalyx in NPC disease cellular model.

2018-03-21 | PXD008438 | Pride

Elevated cerebrospinal fluid ubiquitin C-terminal hydrolase-L1 levels correlate with phenotypic severity and therapeutic response in Niemann-Pick disease, type C1.

Project description: Not available

| S-EPMC10803635 | biostudies-literature

Miglustat in Niemann-Pick disease type C patients: a review.

Project description: Not available

| S-EPMC6094874 | biostudies-literature